Quotient Therapeutics
PrivateLast Round
Corporate Funding
Mar 24, 2026
Total Funding Raised
$70M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Quotient Therapeutics is a biotechnology company that utilizes a somatic genomics platform to discover genetically validated targets and develop transformative therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quotient Therapeutics Comparables
Compare Quotient Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProFound Therapeutics | 78% | |
| Valo Health | 74% | |
| Empirico | 74% | |
Quotient Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 24, 2026 | ||||
| Series A | Nov 21, 2023 |
Key People
Founding team and executive leadership
Quotient Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Multi-year agreement to discover drug targets for inflammatory bowel disease.
- Apr 29, 2025
Rahul Kakkar, M.D. joins as Chief Executive Officer.
Quotient Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quotient Therapeutics's valuation, stock price, and market status.